Current Management Options for Hereditary Angioedema

@article{Bork2012CurrentMO,
  title={Current Management Options for Hereditary Angioedema},
  author={K. Bork},
  journal={Current Allergy and Asthma Reports},
  year={2012},
  volume={12},
  pages={273-280}
}
  • K. Bork
  • Published 2012
  • Medicine
  • Current Allergy and Asthma Reports
  • The aim of treatment of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (HAE-C1-INH) is either treating acute attacks or preventing attacks by using prophylactic treatment. For treating acute attacks, plasma-derived C1 inhibitor (C1-INH) concentrates, a bradykinin B2 receptor antagonist, and a recombinant human C1-INH are available in Europe. In the United States, a plasma-derived C1-INH concentrate, a bradykinin B2 receptor antagonist, and a plasma kallikrein inhibitor have… CONTINUE READING
    21 Citations
    Acute Management of Hereditary Angioedema Attacks.
    • C. Katelaris
    • Medicine
    • Immunology and allergy clinics of North America
    • 2017
    • 5
    Current pharmacotherapy of bradykinin-mediated angioedema
    • H. Farkas
    • Medicine
    • Expert opinion on pharmacotherapy
    • 2013
    • 35
    Hereditary angioedema: what the gastroenterologist needs to know
    • 18
    • PDF
    C1-Esterase Inhibitor: Biological Activities and Therapeutic Applications
    • 13
    • PDF

    References

    SHOWING 1-10 OF 45 REFERENCES
    Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
    • 115
    Long-Term Prophylaxis of Hereditary Angioedema with a Pasteurized C1 Inhibitor Concentrate
    • G. A. Tallroth
    • Medicine
    • International Archives of Allergy and Immunology
    • 2010
    • 18
    Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate.
    • 288
    Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
    • 188
    Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week
    • K. Bork, J. Hardt
    • Medicine
    • International Archives of Allergy and Immunology
    • 2010
    • 45
    Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
    • A. Davis
    • Medicine
    • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
    • 2008
    • 62
    Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    • 286
    Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.
    • K. Bork, A. Bygum, J. Hardt
    • Medicine
    • Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
    • 2008
    • 167